A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

Clinical trial NCT05091346 · COMPLETED

Trial details

NCT number: NCT05091346
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Carcinoma, Hepatocellular Colorectal Neoplasms

Start date: 2021-10-27
Primary completion: 2024-10-15
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.